Innoviva Inc (NAS:INVA)
$ 16.04 0.1 (0.63%) Market Cap: 1.00 Bil Enterprise Value: 1.27 Bil PE Ratio: 7.23 PB Ratio: 1.43 GF Score: 86/100

Innoviva Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 05:50PM GMT
Release Date Price: $13.17 (+0.08%)
Louise Chen
Cantor Fitzgerald - Analyst

Hi, good day, my name is Louise Chen, I'm the large-cap pharma, biopharma, biotech analyst here at Cantor, very pleased to have with us today the CEO of Innoviva, Pavel Raifeld.

Questions & Answers

Louise Chen
Cantor Fitzgerald - Analyst

So Pavel, to start, could you tell us a little bit about your company and also what your strategic vision is over the next three to five years?

Pavel Raifeld
Innoviva, Inc. - CEO

Sure, hi. Thank you very much, Louise, and it's really a pleasure to be here and to see everyone. So Innoviva is a very, very interesting company and a company I'm very passionate and excited about as one would expect.

So we started out as a royalty company, our background was that a number of years ago, we created a technology, which we then partnered out to GSK. And we've been receiving very considerable royalties to the tune of say, [quarter of a billion dollar] of cash flow a year from that.

And so over the past three years, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot